|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Revance Therapeutics (NASDAQ: RVNC) through any online brokerage.
The latest price target for Revance Therapeutics (NASDAQ: RVNC) was reported by HC Wainwright & Co. on February 23, 2021. The analyst firm set a price target for 35.00 expecting RVNC to rise to within 12 months (a possible 11.71% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $31.33 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Revance Therapeutics.
There is no upcoming split for Revance Therapeutics.
Revance Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.